Monitoring of the Immune Dysfunction in Cancer Patients

Author： Santegoets Saskia J. A. M.   Welters Marij J. P.   van der Burg Sjoerd H.  

Publisher： MDPI

E-ISSN： 2076-393x|4|3|29-29

ISSN： 2076-393x

Source： Vaccines, Vol.4, Iss.3, 2016-09, pp. : 29-29

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment

By Tunger Antje   Kießler Maximilian   Wehner Rebekka   Temme Achim   Meier Friedegund   Bachmann Michael   Schmitz Marc  

Biomedicines, Vol. 6, Iss. 1, 2018-03 ,pp. : 26-26

MDPI

Access to resources Recommend Favorite

Immune Dysfunction in Uremia—An Update

By Cohen Gerald   Hörl Walter H.  

Toxins, Vol. 4, Iss. 11, 2012-10 ,pp. : 962-990

MDPI

Access to resources Recommend Favorite

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

By Larsen Stine Kiaer   Hansen Morten   Svane Inge Marie   Straten Per Thor   Andersen Mads Hald  

Cells, Vol. 1, Iss. 2, 2012-04 ,pp. : 51-60

MDPI

Access to resources Recommend Favorite

The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction

By Schnell Annette   Schmidl Christian   Herr Wolfgang   Siska Peter J.  

Biomedicines, Vol. 6, Iss. 1, 2018-02 ,pp. : 25-25

MDPI

Access to resources Recommend Favorite

Immunotherapy and Immune Evasion in Prostate Cancer

By Thakur Archana   Vaishampayan Ulka   Lum Lawrence G.  

Cancers, Vol. 5, Iss. 2, 2013-05 ,pp. : 569-590

MDPI

Access to resources Recommend Favorite